Edward Andraos, MD
Vascular Surgery · Miami Beach, FLNPI 1417396193
Payments from drug & device makers
Across 277 payments — averaging $97.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$9K
- W. L. Gore & Associates, Inc.$2K
- Cook Medical LLC$2K
- Silk Road Medical, Inc.$2K
- Endologix LLC$2K
- Bolton Medical Inc$2K
- plus $8K from 32 others
What the payments were for
- Travel & lodging$3,73616%
- Food & beverage$19,79784%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Penumbra, Inc. | 38 | $8,970 |
| W. L. Gore & Associates, Inc. | 18 | $2,498 |
| Cook Medical LLC | 30 | $2,162 |
| Silk Road Medical, Inc. | 20 | $1,984 |
| Endologix LLC | 17 | $1,898 |
| Bolton Medical Inc | 20 | $1,584 |
| Boston Scientific | 18 | $1,296 |
| Medtronic(2 entities) | 13 | $963 |
| Shockwave Medical, Inc | 17 | $959 |
| Inari Medical, Inc. | 6 | $755 |
| Bard Peripheral Vascular, Inc. | 7 | $610 |
| Abbott | 10 | $502 |
| Getinge USA Sales, LLC | 8 | $391 |
| Philips North America LLC | 3 | $271 |
| Cagent Vascular Inc | 1 | $266 |
| Dilon Technologies, Inc. | 8 | $216 |
| Johnson & Johnson | 11 | $210 |
| Medistim USA, Inc. | 1 | $195 |
| Cvrx, Inc. | 1 | $149 |
| Imperative Care, Inc | 3 | $143 |
| Biom'up France SAS | 1 | $140 |
| Kerecis Limited | 1 | $118 |
| Sirtex Medical Inc | 3 | $110 |
| Contego Medical, Inc | 1 | $108 |
| Surmodics, Inc. | 4 | $99 |
| Solventum Corporation | 2 | $50 |
| Angiodynamics, Inc. | 2 | $50 |
| Argon Medical Devices, Inc. | 3 | $47 |
| Stryker | 1 | $46 |
| Vesper Medical | 1 | $36 |
| Humacyte Global, Inc. | 1 | $23 |
| Flowphysix Inc | 1 | $22 |
| Smith+Nephew | 1 | $21 |
| KCI USA, Inc. | 1 | $21 |
| Inspiremd Ltd | 1 | $21 |
| Mozarc Medical US LLC | 1 | $21 |
| Acell, Inc. | 1 | $15 |
| Cordis US CORP. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Neuroprotection System$2,482
- Indigo System$2,377
- Penumbra Coil 400$1,455
- GORE TAG Thoracic Endoprosthesis$1,256
- ENROUTE Transcarotid Stent$1,141
- Penumbra System$967
- FLOWTRIEVER CATHETER, S$840
- Zenith Alpha$670
- RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM$629
- RUBY Coil$488
- CT THROMBECTOMY SYSTEM KIT$486
- TREO ABDOMINAL STENT-GRAFT SYSTEM$469
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$463
- Torus Stent Graft System$435
- ENDOCROSS Device$435
- ENROUTE Transcarotid Stent System$423
- ENHANCE Transcarotid Peripheral Access Kit$423
- ENROUTE 0.014 Guidewire$423
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$359
- Kerecis Omega3 Marigen$354
How this compares
$26,983 in reported general payments places this provider in the 80th percentile of 385 vascular surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 67 | $62,081 |
| EliquisApixaban | 15 | $14,750 |
| ClopidogrelClopidogrel Bisulfate | 143 | $1,126 |
| Cilostazol | 48 | $718 |
| Gabapentin | 44 | $549 |
| Pregabalin | 15 | $367 |
| Atorvastatin Calcium | 37 | $295 |
| Diazepam | 24 | $15 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $210 | $62,08167 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 385 vascular surgery providers in Florida.
Other vascular surgery in Miami Beach
- Micheal AyadMiami Beach$209K
- Samuel TapperStuart$1.3M
- Erin MooreJacksonville$488K
- Mariano ArosemenaBradenton$472K
- Woongchae LeeBoca Raton$414K
- Manuel Perez IzquierdoOrlando$396K
- Murray ShamesTampa$354K
- Joseph RicottaDelray Beach$344K
- Martin BackTampa$303K
- Rajesh MalikNaples$296K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.